Important pharmacy news and late-breaking industry information updated daily.
Local pharmacies can still have a competitive edge, however
Researchers investigated the effect of post-discharge thromboprophylaxis in patients hospitalized for a medical illness but still at risk for venous thromboembolism upon release. The MARINER clinical trial randomized high-risk patients to a 45-day course of rivaroxaban or to placebo.
Agency also approves new REMS education Blueprint, changes in safety labeling
HHS this week awarded over $1 billion in opioid-specific grants. The awards support the agency's Five-Point Opioid Strategy, which was launched last year and enhanced this week.
FDA announced that it has approved the final Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS).
Honorees are Lisa Tonrey, Balls Food Stores, Federal Bureau of Prisons pharmacy programs
The Senate on Monday passed legislation enabling pharmacists to inform consumers when it is cheaper to buy a drug without insurance. The Patient Right to Know Act bans the use of gag clauses in insurance plans offered in the private market. The Senate earlier this month passed a similar bill barring these provisions in Medicare.
NEJM study: No real cardiovascular benefit, but daily aspirin may raise risk of hemorrhage
CDC guideline may have contributed to improved prescribing behavior, study finds
New research questions the value of low-dose aspirin for the prevention of heart attacks, strokes, dementia and cancer among healthy older adults.